Alteryx (AYX) PT Lowered to $66 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Alteryx (AYX) PT Lowered to $60 at Loop Capital
February 16, 2022 6:53 AM ESTLoop Capital analyst Yun Kim lowered the price target on Alteryx (NYSE: AYX) to $60.00 (from $80.00) while maintaining a Hold rating.... More
Alteryx (AYX) PT Lowered to $87 at Rosenblatt
February 16, 2022 6:29 AM ESTRosenblatt analyst Blair Abernethy lowered the price target on Alteryx (NYSE: AYX) to $87.00 (from $100.00) while maintaining a Buy rating following strong results with the could product offering expanding.
The analyst commented, "Tuesday after market close, Alteryx reported Q4 results that were above our... More
William Blair Reiterates Outperform Rating on Alteryx (AYX), Sees Stock as Materially Undervalued and as a Buying Opportunity
February 16, 2022 6:00 AM ESTWilliam Blair analyst Kamil Mielczarek reiterated an Outperform rating and {REMOVEPT} price target on Alteryx (NYSE: AYX)
The analyst quotes: "
Alteryxs December quarter results came in slightly above preannounced estimates. Guidance for the March quarter and calendar 2022 was broadly strong. ARR is expected to grow 27% at the midpoint to $810 million and revenue growth is expected to accelerate... More
Alteryx (AYX) PT Lowered to $127 at JMP Securities
February 16, 2022 2:12 AM ESTJMP Securities analyst Patrick Walravens lowered the price target on Alteryx (NYSE: AYX) to $127.00 (from $159.00) while maintaining a Market Outperform rating.... More
Alteryx (AYX) PT Raised to $70 at JPMorgan
February 16, 2022 1:11 AM ESTJPMorgan analyst Mark Murphy raised the price target on Alteryx (NYSE: AYX) to $70.00 (from $65.00) while maintaining a Neutral rating.... More
After-Hours Stock Movers 02/15: (HOOK) (UPST) (AYX) Higher; (RBLX) (TOST) (VIAC) Lower (more...)
February 15, 2022 5:51 PM ESTAfter-Hours Stock Movers:
HOOKIPA Pharma Inc. (NASDAQ: HOOK) 53.7% HIGHER; entered into an amended and restated collaboration and license agreement with Gilead to advance the development of a novel arenaviral immunotherapy as a component of a potential functional curative regimen for human immunodeficiency virus (HIV).
Upstart Holdings (NASDAQ: UPST) 21.9% HIGHER; reported Q4 EPS of $0.89, $0.38 better than the analyst estimate of $0.51. Revenue for the quarter came in at $304.8 million versus the... More
Alteryx (AYX) Tops Q4 EPS by 12c
February 15, 2022 4:12 PM ESTAlteryx (NYSE: AYX) reported Q4 EPS of $0.17, $0.12 better than the analyst estimate of $0.05. Revenue for the quarter came in at $173.8 million versus the consensus estimate of $165.79 million.
GUIDANCE:
Alteryx sees FY2022 EPS of ($0.68)-($0.58), versus the consensus of ($0.08). Alteryx sees... More
